Cures Within Reach

In need of funding? We have 3 RFPs open now: AI Validation, Veterans or Chicago-focused, all testing approved therapies in unsolved diseases in Phase 1/2A trials. LOIs due May/June. Join an upcoming info session and learn more at https://www.cureswithinreach.org/programs/funding-opportunities-rfps/.

Funding Opportunities / RFPs - Cures Within Reach Funding opportunities for clinical trials repurposing research in any unsolved disease.

During , we are proud to now fund an open label crossover pilot trial “Using a Wearable Leg Stimulation Device to Improve Mobility of Veterans with Parkinson’s” led by Dr. Kalea Colletta of Hines VA Hospital.

https://www.cureswithinreach.org/2025/12/17/using-a-wearable-leg-stimulation-device-to-improve-mobility-of-veterans-with-parkinsons/

Chicago is a major hub for clinical research, and we’re growing the happening across the city with our funding of 5 new trials at Chicago-based research institutions. Focused on areas where patients urgently need better options. By testing already approved therapies, our approach helps move potential treatments to patients faster and at a lower cost. With the support of partners including the Searle Funds at The Chicago Community Trust, we are also expanding our investment in early-stage investigators, critical as traditional medical research funding is becoming harder to secure. https://www.cureswithinreach.org/2026/04/09/press-release-cwr-approves-five-clinical-trials-at-chicago-institutions/
Lurie Children's Hospital
The University of Chicago
Hines VA Hospital

During Awareness Month, we are proud to now be funding an ongoing Phase IIA trial “Treating with Stellate Ganglion Block via TMS Neuromodulation” led by Dr. Yosef Berlow at Providence VA Medical Center and Ocean State Research Institute.
VA Providence Healthcare System

Treating PTSD with Stellate Ganglion Block via TMS Neuromodulation - Cures Within Reach There is an urgent need for new therapeutic approaches to treating patients with PTSD, as current treatment options often fail to alleviate symptoms for many. This Phase IIA, multi-arm, placebo-controlled trial is testing a neuromodulation method, applying a transcranial magnetic stimulation (TMS) d...